Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from Medicine Man Technologies ( (SHWZ) ) is now available.
On April 15, 2025, Medicine Man Technologies, Inc. appointed Bob Finley as the Interim Chief Financial Officer, effective April 21, 2025, while the company continues its search for a permanent CFO. Finley, a partner at FLG Partners, brings over 25 years of experience in high-growth sectors, including cannabis, and will serve as a non-employee consultant under a 12-week agreement with FLG Partners, which includes a monthly payment of $100,000 and indemnification provisions.
Spark’s Take on SHWZ Stock
According to Spark, TipRanks’ AI Analyst, SHWZ is a Neutral.
Medicine Man Technologies faces considerable financial and operational risks, with weak profitability and high leverage. Technical indicators suggest bearish momentum, and valuation metrics highlight a lack of attractiveness. Corporate events add further uncertainty. The new leadership might bring positive change, but significant challenges need addressing.
To see Spark’s full report on SHWZ stock, click here.
More about Medicine Man Technologies
YTD Price Performance: -45.00%
Average Trading Volume: 6,794
Technical Sentiment Signal: Buy
Current Market Cap: $430.4K
Find detailed analytics on SHWZ stock on TipRanks’ Stock Analysis page.